TY - JOUR
T1 - Current trends in neurotrauma care
AU - Timmons, Shelly D.
N1 - Funding Information:
The author has held consultancies with Integra, received grants from the National Institutes of Health and the UT Neuroscience Institute, and received honoraria from Synthes.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2010/9
Y1 - 2010/9
N2 - Severe traumatic brain injury remains a significant cause of mortality and morbidity worldwide. The use of therapeutic interventions such as hypertonic saline administration and decompressive craniectomy have solid foundations and can improve outcomes, although questions remain about patient selection, optimal timing, and comparisons to other treatments. Hypothermia, while having promise, has not definitively been shown to benefit patients with traumatic brain injury, although clinical trials are underway. The use of β-blockers in traumatic brain injury has been proposed as a neuroprotective measure, but data are lacking to support widespread clinical use. Brain tissue oxygenation monitoring is gaining widespread acceptance as a safe tool to provide additional information both to guide therapeutic interventions and to further elucidate mechanisms of secondary brain injury. Evidence is also mounting that guided therapy using brain tissue oxygenation in addition to intracranial pressure and cerebral perfusion pressure monitoring leads to better outcomes after traumatic brain injury.
AB - Severe traumatic brain injury remains a significant cause of mortality and morbidity worldwide. The use of therapeutic interventions such as hypertonic saline administration and decompressive craniectomy have solid foundations and can improve outcomes, although questions remain about patient selection, optimal timing, and comparisons to other treatments. Hypothermia, while having promise, has not definitively been shown to benefit patients with traumatic brain injury, although clinical trials are underway. The use of β-blockers in traumatic brain injury has been proposed as a neuroprotective measure, but data are lacking to support widespread clinical use. Brain tissue oxygenation monitoring is gaining widespread acceptance as a safe tool to provide additional information both to guide therapeutic interventions and to further elucidate mechanisms of secondary brain injury. Evidence is also mounting that guided therapy using brain tissue oxygenation in addition to intracranial pressure and cerebral perfusion pressure monitoring leads to better outcomes after traumatic brain injury.
UR - http://www.scopus.com/inward/record.url?scp=77956212592&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956212592&partnerID=8YFLogxK
U2 - 10.1097/CCM.0b013e3181ec57ab
DO - 10.1097/CCM.0b013e3181ec57ab
M3 - Article
C2 - 20724876
AN - SCOPUS:77956212592
SN - 0090-3493
VL - 38
SP - S431-S444
JO - Critical care medicine
JF - Critical care medicine
IS - SUPPL. 9
ER -